about
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Read More
12.97
-0.02
(-0.15%)
454.5K
XNAS Volume
High vol. this week
XNAS 04 Dec, 2025 12:57 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
DBV Tech (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..